TAILIEUCHUNG - Pharmaceutical Substances Syntheses, Patents, Applications - Part 137

Pharmaceutical Substances Syntheses, Patents, Applications - Part 137. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Montelukast sodium M 1361 aa synthesis of intermediate VI OH OH soci2 ch2ci2 ---------------- NaCN CH2CI2 -------------- NC OH 1 1 -cyclopropanedimethanol 2- 1 - hydroxymethyl -cyclop ropyl -acetonitrile VUI 1. h3cso2ci n c2h5 3 2. H3C CO SK Vin ---------------------------- 1. mesyl chloride 2. potassium thioacetate NoOH taluene H2O ----------------- 2 1 - ocetylthio -cyclopropyl ocetonitrile LiAIH4 THF 0 pyridine CH2CI2 benzoyl chloride IX diethyl 1. h3cso2ci 2. NaCN DMSO ---------------- K 2- 1- benzoyloxy- methyl cyclopropyl - acetonitrile X 1. KOH ethonol 2. CH2N2 8 3. H3C S Cl 2 u H-jC SCs CH2CI2 ----------- cesium thioacetate methyl 2- 1- acetyl-thiomethyl cyclopropyl -acetate XI xn 1362 M Moperone xni 1. Tos OH pyridine 2. NaOH --- ------------- Montelukast sodium fH3 ÇHj 1. Cl ----I---CH3k ch3 ch3 DMAP CH2CI2 XIV 1. tert-butyldimethyl-silyl chloride 2. 3 4-dihydro-2H-pyran 1. Bu4N F . THF L. 2. HjC Cl 0 MV XII Reference s a EP 480 717 Merck Frosst appl. USA-prior. . aa US 5 523 477 Merck Co. USA-prior. . b wo 9 518 107 Merck Co. appl. USA prior. . Labelle M. et al. Bioorg. Med. Chem. Lett. BMCLE8 5 283 1995 . synthesis of starting material I US 4 851 409 Merck Frosst Can. USA-prior. . pharmaceutical composition with loratidine WO 9 728 797 Merck Co. appl. USA-prior. . Formulation s chewable tabl. 5 mg 50 mg f. c. tabl. 10 mg tabl. 5 mg 10 mg as sodium salt Trade Name s D Singulair MSD I Lukasm Sigmatau USA Singulair Merck Sharp Dieckmann Montegen Gentili Dohme 1998 GB Singulair Merck Sharp Singulair Merck Sharp Dohme Dohme Moperone Methylperidol Mopiperone ATC N05AD04 Use neuroleptic antipsychotic RN 1050-79-9 MF C22H26FNO2 MW EINECS 213-887-6 CN l- 4-fluorophenyl -4- 4-hydroxy-4- 4-methylphenyl -l-piperidinyl -l-butanone Mopidamol M 1363 hydrochloride RN 3871-82-7 MF C22H26FNO2 HC1 MW EINECS

Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.